HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 290/3/E494    most recent 00304.2005v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (3) Citing Articles via Google Scholar Google Scholar Articles by Wang, C. Articles by Ling, Z. Search for Related Content PubMed PubMed Citation Articles by Wang, C. Articles by Ling, Z.

Glucose inhibits GABA release by pancreatic -cells through an increase in GABA shunt activity

¹Diabetes Research Center, Brussels Free University-Vrije Universiteit Brussel, and Juvenile Diabetes Research Foundation Center for Beta Cell Therapy; and ²Department of Pharmaceutical Chemistry and Drug Analysis, Brussels Free University-VUB, Brussels, Belgium

Submitted 5 July 2005 ; accepted in final form 17 October 2005

GABA is the major inhibitory neurotransmitter in the nervous system. It is also released by the insulin-producing -cells, providing them with a potential paracrine regulator. Because glucose was found to inhibit GABA release, we investigated whether extracellular GABA can serve as a marker for glucose-induced mitochondrial activity and thus for the functional state of -cells. GABA release by rat and human -cells was shown to reflect net GABA production, varying with the functional state of the cells. Net GABA production is the result of GABA formation through glutamate decarboxylase (GAD) and GABA catabolism involving a GABA-transferase (GABA-T)-mediated shunt to the TCA cycle. GABA-T exhibits K_m values for GABA (1.25 mM) and for -ketoglutarate (-KG; 0.49 mM) that are, respectively, similar to and lower than those in brain. The GABA-T inhibitor -vinyl GABA was used to assess the relative contribution of GABA formation and catabolism to net production and release. The nutrient status of the -cells was found to regulate both processes. Glutamine dose-dependently increased GAD-mediated formation of GABA, whereas glucose metabolism shunts part of this GABA to mitochondrial catabolism, involving -KG-induced activation of GABA-T. In absence of extracellular glutamine, glucose also contributed to GABA formation through aminotransferase generation of glutamate from -KG; this stimulatory effect increased GABA release only when GABA-T activity was suppressed. We conclude that GABA release from -cells is regulated by glutamine and glucose. Glucose inhibits glutamine-driven GABA formation and release through increasing GABA-T shunt activity by its cellular metabolism. Our data indicate that GABA release by -cells can be used to monitor their metabolic responsiveness to glucose irrespective of their insulin-secretory activity.

glutamine; -aminobutyric acid; -aminobutyric acid transferase

This article has been cited by other articles:

				P. Bansal and Q. Wang Insulin as a physiological modulator of glucagon secretion Am J Physiol Endocrinol Metab, October 1, 2008; 295(4): E751 - E761. [Abstract] [Full Text] [PDF]

				M. M. Bonaventura, P. N. Catalano, A. Chamson-Reig, E. Arany, D. Hill, B. Bettler, F. Saravia, C. Libertun, and V. A. Lux-Lantos GABAB receptors and glucose homeostasis: evaluation in GABAB receptor knockout mice Am J Physiol Endocrinol Metab, January 1, 2008; 294(1): E157 - E167. [Abstract] [Full Text] [PDF]

				C. Wang, R. Mao, M. Van De Casteele, D. Pipeleers, and Z. Ling Glucagon-like peptide-1 stimulates GABA formation by pancreatic beta-cells at the level of glutamate decarboxylase Am J Physiol Endocrinol Metab, April 1, 2007; 292(4): E1201 - E1206. [Abstract] [Full Text] [PDF]